HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparative study of various schedules of administration of propranolol to patients with stenocardia (a cooperative study)].

Abstract
Forty-eight anginal patients (mean age: 50.3 +/- 1.6 years) were included in the study, carried out in 6 centres. Both the continuous regimen of propranolol (PR) administration (4 or 3 times daily) and the intermittent regimen (twice daily) were associated with a significant drop in the frequency of anginal attacks and the quantity of nitroglycerine pills consumed (p less than 0.05). PR, used for 12 weeks in a regimen, determined by means of paired bicycle ergometric tests, produced an antianginal effect in 85% of anginal patients, the effect being absolute in 35% of those. However, in the "twice-daily" regimen of PR administration, paired bicycle ergometry, conducted in the course of treatment, revealed that antianginal effect was not stable within 12 hours. Treatment courses with higher daily PR doses failed to produce any significant drop in the frequency of anginal attacks as compared to the effect, already achieved with an earlier dose.
Authors
JournalKardiologiia (Kardiologiia) Vol. 29 Issue 2 Pg. 38-42 (Feb 1989) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleSravnitel'noe izuchenie razlichnykh skhem primeneniia propranolola u bol'nykh so stenokardieĭ (kooperativenoe issledovanie).
PMID2498565 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Placebos
  • Tablets
  • Propranolol
  • Nitroglycerin
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Angina Pectoris (drug therapy)
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Humans
  • Middle Aged
  • Multicenter Studies as Topic
  • Nitroglycerin (administration & dosage)
  • Placebos
  • Propranolol (administration & dosage)
  • Tablets
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: